Alcobra Q3 Loss Widens - Quick Facts

(RTTNews) - Alcobra Ltd. (ADHD) posted third-quarter net loss attributable to holders of ordinary shares of $10.5 million or $0.77 per share, wider than $3.1 million or $0.28 per share in the comparable quarter last year.

On average, 7 analysts polled by Thomson Reuters expected the company to report a a loss of $0.56 per share. Analysts' estimates typically exclude special items.

Operating loss for the latest third quarter widened to $10.59 million from $3.14 million in the prior year period.

Research and development or R&D expenses were $8.8 million, compared with $2.1 million in the third quarter of 2013. R&D expenses in the third quarter of 2014 consist primarily of costs associated with the conduct of 3 advanced clinical studies, including the first Phase III study which was recently completed.